MedPath

RIVA-LATANOPROST

RIVA-LATANOPROST

Approved
DIN Number

02341085

Drug Class

Human

Market Date

May 11, 2015

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02341085
AIG Number0132916002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE01 LATANOPROST
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

LATANOPROSTActive
Strength: 50 MCG / ML
Monograph: LATANOPROST

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.